Ignite Creation Date:
2025-12-24 @ 4:25 PM
Ignite Modification Date:
2026-01-16 @ 12:12 PM
Study NCT ID:
NCT07104266
Status:
RECRUITING
Last Update Posted:
2025-08-05
First Post:
2025-07-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Triple Negative Breast Cancer and Celecoxib. Pilot Study
Sponsor:
Université de Sherbrooke
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TNBC2025-5681
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None